<DOC>
	<DOCNO>NCT02386501</DOCNO>
	<brief_summary>This Phase 1b , multicenter , open-label , dose-escalation study design estimate maximum tolerate dose ( MTD ) determine recommend Phase 2 dose ( RP2D ) ADXS31-164 . Once RP2D select , 4 expansion cohort evaluate .</brief_summary>
	<brief_title>Dose Escalation Study ADXS31-164 Subjects With HER2 Expressing Solid Tumors</brief_title>
	<detailed_description />
	<criteria>HER2 Positive Have histological cytological diagnosis locally advanced/metastatic HER2 solid tumor progress become intolerant standard therapy standard therapy available Have measurable and/or evaluable disease base RECIST 1.1 . ECOG performance status 0 1 Is newly diagnose curative treatment option available . Has diagnosis immunodeficiency receive systemic steroid therapy form ' immunosuppressive therapy within 7 day prior first dose trial treatment . Has prior monoclonal antibody therapy within 2 week prior study Day 1 . ( Prior antiHER2 therapy acceptable ) . Has receive anticancer chemotherapy , surgical treatment , and/or radiation therapy ( except palliative radiation therapy diseaserelated pain consult sponsor 's medical monitor ) within â‰¤2 week first study treatment . Is dependent , currently receive within past 4 week corticosteroid ( hormone replacement therapy , topical corticosteroid occasional inhaled corticosteroid allow ) . Has contraindication administration trimethoprim/sulfamethoxazole ampicillin . Has implant medical device ( ) pose high risk colonization and/or easily remove ( e.g. , prosthetic joint , artificial heart valve , pacemaker , orthopedic screw ( ) , metal plate ( ) , bone graft ( ) , exogenous implant ( ) ) . NOTE : More common device prosthetics include arterial venous stent , dental breast implant , venous access device ( e.g. , PortaCath Mediport ) permit . Sponsor must contact prior consent subject device and/or implant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>